Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 228

Similar articles for PubMed (Select 7502870)

1.

Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea.

Svennerholm AM, Holmgren J.

Adv Exp Med Biol. 1995;371B:1623-8. Review. No abstract available.

PMID:
7502870
3.

Oral immunization against cholera.

Holmgren J, Clemens J, Sack DA, Sanchez J, Svennerholm AM.

Curr Top Microbiol Immunol. 1989;146:197-204. Review. No abstract available.

PMID:
2659268
4.

Cholera as a model for research on mucosal immunity and development of oral vaccines.

Holmgren J, Czerkinsky C.

Curr Opin Immunol. 1992 Aug;4(4):387-91. Review.

PMID:
1388838
5.

A review of the current status of enteric vaccines.

Levine MM, Noriega F.

P N G Med J. 1995 Dec;38(4):325-31. Review.

PMID:
9522876
6.
7.

Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.

Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM.

Am J Trop Med Hyg. 1994;50(5 Suppl):42-54. Review.

PMID:
8203723
8.

Mucosal vaccines based on the use of cholera toxin B subunit as immunogen and antigen carrier.

Lebens M, Holmgren J.

Dev Biol Stand. 1994;82:215-27. Review.

PMID:
7958476
9.

Parenteral vaccination of mice and piglets with F4+ Escherichia coli suppresses the enteric anti-F4 response upon oral infection.

Bianchi AT, Scholten JW, van Zijderveld AM, van Zijderveld FG, Bokhout BA.

Vaccine. 1996 Feb;14(3):199-206.

PMID:
8920700
10.

The antibody response in infants after oral administration of inactivated and living E. coli vaccines and their protective effect against nosocomial infections.

Lodinová-Zádníková R, Tlaskalová H, Korych B, Bartáková Z.

Adv Exp Med Biol. 1995;371B:1431-8. No abstract available.

PMID:
7502832
11.

Vaccine-specific T cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine.

Wennerås C, Czerkinsky C, Svennerholm AM.

Adv Exp Med Biol. 1995;371B:1641-4. No abstract available.

PMID:
7502873
12.

Towards a live oral vaccine against enterotoxigenic Escherichia coli of swine.

Attridge S, Hackett J, Morona R, Whyte P.

Vaccine. 1988 Oct;6(5):387-9.

PMID:
3057757
13.

Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.

Holmgren J, Svennerholm AM.

Scand J Infect Dis Suppl. 1990;76:47-53. Review.

PMID:
2102020
14.

New vaccines against bacterial enteric infections.

Holmgren J, Svennerholm AM.

Scand J Infect Dis Suppl. 1990;70:149-56. Review.

PMID:
2287897
16.

Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group.

Savarino SJ, Hall ER, Bassily S, Brown FM, Youssef F, Wierzba TF, Peruski L, El-Masry NA, Safwat M, Rao M, El Mohamady H, Abu-Elyazeed R, Naficy A, Svennerholm AM, Jertborn M, Lee YJ, Clemens JD.

J Infect Dis. 1999 Jan;179(1):107-14.

17.

Recombinant DNA technology and enterotoxigenic Escherichia coli vaccines.

Gyles CL, Maas WK.

Prog Vet Microbiol Immunol. 1987;3:139-58. Review. No abstract available.

PMID:
3078832
18.

Statement on new oral cholera and travellers' diarrhea vaccination.

Committee to Advise on Tropical Medicine and Travel (CATMAT); National Advisory Committee on Immunization (NACI).

Can Commun Dis Rep. 2005 Jul 1;31(ACS-7):1-11. English, French. No abstract available.

19.

Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea.

Steffen R, Castelli F, Dieter Nothdurft H, Rombo L, Jane Zuckerman N.

J Travel Med. 2005 Mar-Apr;12(2):102-7. Review. No abstract available.

PMID:
15996455
20.

Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.

Leyten EM, Soonawala D, Schultsz C, Herzog C, Ligthelm RJ, Wijnands S, Visser LG.

Vaccine. 2005 Oct 17;23(43):5120-6.

PMID:
15982790
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk